Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study

Abstract

Genotypic testing at low viral load may identify emerging antiretroviral drug resistance at an early stage, and thus might be successfully employed in guiding prompt management strategies that may reduce the accumulation of resistance and cross-resistance, viral adaptive changes, and larger viral load increases.